Comparator Sourcing for Cancer Drugs: Keytruda®, Avastin®, Pomalidomide®

In clinical trials, the race to find a cure for cancer, is one of the most challenging that researchers face. When seeking comparators, cost, speed and appropriate documentation is undoubtedly a key factor in the acquisition of vital medication.

According to Cancer Research UK, there are currently more than 200 types of cancer.  These are contained within 5 principal groups: 

Carcinoma: the most common type of cancer which originates in the skin or within the tissues lining or covering internal organs.

Sarcoma: less common than carcinoma, there are 2 main types – bone sarcomas and soft tissue sarcomas. These develop within supportive tissues within the body, such as bone, cartilage, fat, muscle, or blood vessels. 

Leukemia: a cancer which affects white blood cells and commences in the tissues responsible for the production of blood cells, e.g. bone marrow. Leukemia accounts for 3% of all cancer cases but is the most common cancer amongst children.

Lymphoma and Myeloma: lymphoma cancer is a cancer within the lymphatic system which is responsible for supporting our immune system. Myeloma cancer is found in plasma cells, a type of white blood cell within the bone marrow which produces antibodies to help fight infection.

Brain and Spinal Cord Cancers: These are collectively known as central nervous system cancers. They develop in the tissues of the brain and spinal cord. In some instances, these can be benign tumours or tumours which develop very slowly. In other instances, they can become cancerous growing and spreading.

Oximio’s Access to Leading Cancer Drugs

At Oximio, there are three stand-out oncology drugs in demand for clinical trials. These are:

Keytruda® (Pembrolizumab®): Due to the success of Keytruda®, across a variety of cancer treatments and its ability to delay the deterioration of cancers, it is quickly emerging as one of the most popular drugs used within oncology clinical trials today.

Avastin®: blocking the blood supply that feeds a tumour and curtailing its growth, Oximio has seen increased demand for this cancer drug.

Pomalidomide®: supplied under the name of Pomalyst® or Imnovid®, this targeted immunotherapy drug is used to target myeloma. Available in capsule format, it is easily ingested.

When it comes to comparator sourcing for cancer drugs, Oximio can offer the best price in the market for Keytruda®, Avastin® and Pomalidomide®. With an extensive global presence, Oximio is able to source medicines at both a local and international level. We can carry out comprehensive and impartial assessments of comparators and offer these at a highly competitive price, in some instances with savings of thousands of euros. All medicinal products are accompanied with comprehensive regulatory documentation (eg: Certificate of Analysis; Certificate of Pedigree etc) , underscoring product quality together with supply chain traceability. Thanks to our skilled procurement teams across all our locations, we have the experience and expertise to handle the complexities of expiration dates, batch specifications, and shortest lead times.

For further information and the latest prices of our comparators for cancer and other disease, please contact us.